CDTX(CDTX)
CDTX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $8M | $12M | $383M | $808M |
| Low | $8M | $12M | $383M | $808M |
| High | $8M | $12M | $383M | $808M |
| EBITDA Avg | $-7M | $-10M | $-334M | $-705M |
| Low | $-7M | $-10M | $-334M | $-705M |
| High | $-7M | $-10M | $-334M | $-705M |
| EBIT Avg | $-7M | $-10M | $-335M | $-706M |
| Low | $-7M | $-10M | $-335M | $-706M |
| High | $-7M | $-10M | $-335M | $-706M |
| Net Income Avg | $-38M | $-45M | $3M | $42M |
| Low | $-54M | $-63M | $-39M | $42M |
| High | $-22M | $-27M | $101M | $42M |
| EPS Avg | $-6.24 | $-6.33 | $1.37 | $6.63 |
| Low | $-8.49 | $-9.92 | $-6.08 | $6.63 |
| High | $-3.42 | $-4.30 | $15.83 | $6.63 |
| Analysts (Rev / EPS) | 4 / 4 | 6 / 6 | 4 / 3 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | — | — |
| Low | — | — |
| High | — | — |
| EBITDA Avg | — | — |
| Low | — | — |
| High | — | — |
| EBIT Avg | — | — |
| Low | — | — |
| High | — | — |
| Net Income Avg | $-15M | $-14M |
| Low | $-15M | $-14M |
| High | $-15M | $-14M |
| EPS Avg | $-0.96 | $-0.93 |
| Low | $-0.96 | $-0.93 |
| High | $-0.96 | $-0.93 |
| Analysts (Rev / EPS) | — / 1 | — / 1 |